Managing recurrence presents several challenges, including treatment resistance, patient compliance, and the identification of reliable biomarkers. Treatment resistance can arise from genetic mutations that make disease cells less responsive to conventional therapies. Ensuring patient compliance with follow-up appointments and treatment regimens is also critical for early detection and management of recurrence. Identifying reliable biomarkers that can predict recurrence remains an ongoing area of research in histology.
